Pliant Therapeutics, Inc. (PLRX) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Third Rock Ventures III, L.P. mit 1,839,160 Aktien. Weitere bedeutende Anteilseigner sind Coulie Bernard und Cummings Keith Lamont.
In den letzten 12 Monaten haben Insider 18 Transaktionen in PLRX Aktien getätigt — 13 Käufe (im Wert von $3.33M) und 4 Verkäufe (im Wert von $163.62K). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
PLRX Insider-Beteiligungen
Größter Aktionär
Third Rock Ventures III, L.P.
1,839,160 Aktien
Käufe (12 Monate)
13
$3.33M Wert
Verkäufe (12 Monate)
4
$163.62K Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Third Rock Ventures Iii, L.p. |
Director |
1,839,160 |
2022-12-01 |
|
| 2 |
Coulie Bernard |
President and CEO |
1,230,000 |
2026-01-26 |
|
| 3 |
Cummings Keith Lamont |
Chief Financial Officer |
400,000 |
2026-01-26 |
|
| 4 |
Cheung Lily |
Chief Human Resource Officer |
300,000 |
2026-01-26 |
|
| 5 |
Kuo Minnie |
Chief Operating Officer |
300,000 |
2026-01-26 |
|
| 6 |
Lefebvre Eric |
Chief Medical Officer |
91,300 |
2025-01-27 |
|
| 7 |
Hull Hans |
Chief Business Officer |
80,300 |
2025-01-27 |
|
| 8 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
70,000 |
2025-01-27 |
|
| 9 |
Howes Barbara |
Chief Human Resource Officer |
42,500 |
2021-01-26 |
|
| 10 |
Crowell Gayle A |
Director |
30,000 |
2025-06-09 |
|
| 11 |
Knobil Katharine |
Director |
30,000 |
2025-06-09 |
|
| 12 |
Curnutte John T |
Director |
30,000 |
2025-06-09 |
|
| 13 |
Bruhn Suzanne Louise |
Director |
30,000 |
2025-06-09 |
|
| 14 |
Mccourt Thomas A |
Director |
30,000 |
2025-06-09 |
|
| 15 |
Krognes Steve E. |
Director |
30,000 |
2025-06-09 |
|
| 16 |
Cline Darren S |
Director |
30,000 |
2025-06-09 |
|
| 17 |
Huh Hoyoung |
Director |
30,000 |
2025-06-09 |
|
| 18 |
Pyott David E I |
Director |
30,000 |
2025-06-09 |
|
| 19 |
Shah Smital |
Director |
26,764 |
2024-06-17 |
|
| 20 |
Exter Neil |
Director |
15,000 |
2022-06-21 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-01-22 |
Kuo Minnie |
Chief Operating Officer |
RSU-Zuteilung |
300,000 |
$1.30 |
$390K |
| 2026-01-22 |
Cheung Lily |
Chief Human Resource Officer |
RSU-Zuteilung |
300,000 |
$1.30 |
$390K |
| 2026-01-22 |
Cummings Keith Lamont |
Chief Financial Officer |
RSU-Zuteilung |
400,000 |
$1.30 |
$520K |
| 2026-01-22 |
Coulie Bernard |
President and CEO |
RSU-Zuteilung |
1,230,000 |
$1.30 |
$1.6M |
| 2026-01-20 |
Kuo Minnie |
Chief Operating Officer |
Informierter Verkauf |
6,917 |
$1.28 |
$8.85K |
| 2026-01-20 |
Cheung Lily |
Chief Human Resource Officer |
Informierter Verkauf |
7,534 |
$1.28 |
$9.64K |
| 2026-01-20 |
Cummings Keith Lamont |
Chief Financial Officer |
Informierter Verkauf |
24,002 |
$1.28 |
$30.72K |
| 2026-01-20 |
Coulie Bernard |
President and CEO |
Informierter Verkauf |
89,375 |
$1.28 |
$114.4K |
| 2025-12-10 |
Kuo Minnie |
Chief Operating Officer |
Unbekannt |
55,200 |
$11.14 |
$614.93K |
| 2025-06-05 |
Knobil Katharine |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Krognes Steve E. |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Cline Darren S |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Curnutte John T |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Bruhn Suzanne Louise |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Mccourt Thomas A |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Huh Hoyoung |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Crowell Gayle A |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
| 2025-06-05 |
Pyott David E I |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
